Comparison of the Efficacy of Two Different Suprascapular Nerve Block Techniques in Patients With Chronic Shoulder Pain
CompletedNot applicableNCT04938037
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The aim of this study is to compare the efficacy and safety of the suprascapular nerve block (SSNB) at the spinoglenoid notch with SSNB at the suprascapular notch, which is the most commonly used technique in patients with chronic shoulder pain.
Study details
- Official title
- Comparison of Efficacy and Safety of Two Different Ultrasound-Guided Suprascapular Nerve Block Techniques in Chronic Shoulder Pain: A Prospective Double-Blinded Randomized Controlled Study
- Conditions
- Interventions
- Procedure: US guided, SSNB with 1ml methylprednisolone acetate (1ml / 40mg) and 5 ml 0.5% bupivacaine
- Sponsor
- TC Erciyes University
- Start date
- 2021-06-01
- Primary completion
- 2022-08-05
- Sex
- All
- Age range
- from 18 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Age ≥ 18 years old 2. Shoulder pain that last more than 3 month 3. Patients with a VAS value of ≥ 4 despite treatment (drugs used for analgesia, local injections and physiotherapy methods) 4. Shoulder pain defined as non-specific shoulder pain, subacromial impingement syndrome, rotator cuff tendinopathy, adhesive capsulitis, non-traumatic instability, SLAP lesion, acromioclavicular pathology, and / or shoulder osteoarthritis. Exclusion Criteria: 1. A history of uncontrolled chronic diseases, e.g., malignant neoplasms, blood dyscrasia, and infection 2. Previous surgery history at the affected shoulder 3. Shoulder injection in the last 3 months before treatment 4. The presence of cervical radiculopathy or myelopathy 5. A previous fracture close to the shoulder region 6. Presence of septic arthritis or local infection in the affected shoulder 7. Presence of anaphylaxis against local anesthetics and / or corticosteroids 8. Presence of a cardiac pacemaker 9. Pregnancy
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04938037